4D pharma: 4D Pharma seeks approval for equity fundraise to lift suspension

(marketscreener.com) 4D Pharma PLC on Friday said it was seeking shareholder approval for a USD15.0 million cash raise, as it works to lift its suspension and restore its shares to trading. The Leeds-based pharmaceutical firm was placed into administration on June 24, 2022, with James Clark and David Pike of Interpath Advisory appointed as joint administrators. On...https://www.marketscreener.com/quote/stock/4D-PHARMA-PLC-56171591/news/4D-Pharma-seeks-approval-for-equity-fundraise-to-lift-suspension-42639094/?utm_medium=RSS&utm_content=20221230